Breadcrumb Home News News K Programs CTSI KL2 co-leader, Elizabeta Nemeth, receives ASH honorific award July 02, 2021 1 min read K Programs CTSI KL2 program opens registration for 2018-19 K & Career Development Seminars Monthly seminars generally take place on the 3rd Tuesday of each month from 3:30-5:00pm April 17, 2018 1 min read Clinical and Translational Research Centers CTSI KL2 scholar helps identify key differences in lungs of cystic fibrosis patients CTSI KL2 scholar helps identify key differences in lungs of cystic fibrosis patients May 17, 2021 1 min read Clinical and Translational Research Centers, Integrating Special Populations, Training Grant Support CTSI KL2 scholar receives two NIH NIA grants to help reduce low-value care for older adults CTSI KL2 scholar receives two NIH NIA grants to help reduce low-value care for older adults January 28, 2021 3 min read CTSI Leadership & Partner News CTSI KL2 scholar Siwen Hu-Lieskovan receives stand up to cancer award to study drug resistance CTSI KL2 scholar Siwen Hu-Lieskovan receives stand up to cancer award to study drug resistance May 18, 2017 1 min read K Programs CTSI KL2 scholars and TL1 trainee to present at ACTS-AFMR Translational Meeting The KL2 Scholars and one TL1 trainee will present posters at the Annual Translational Science Meeting on April 9-11, 2014 in Washington, DC. April 07, 2014 2 min read Clinical and Translational Research Centers, Education & Training CTSI leaders support the COVID-19 research infrastructure at UCLA CTSI leaders support the COVID-19 research infrastructure at UCLA April 02, 2020 3 min read CTSI leaders' team awarded almost $3 million for “Safe Return to School” effort July 16, 2021 1 min read Clinical and Translational Research Centers, Precision Health CTSI leadership to speak at UCLA health data day CTSI leadership to speak at UCLA health data day April 23, 2019 1 min read Clinical and Translational Research Centers CTSI leaders’ team awarded almost $3 million for “safe return to school” effort CTSI leaders’ team awarded almost $3 million for “safe return to school” effort July 06, 2021 1 min read Clinical and Translational Research Centers CTSI lent support to development of FDA-approved "tissue agnostic" cancer drug Larotrectinib is the second "tissue agnostic" drug approved by the FDA December 03, 2018 2 min read Clinical and Translational Research Centers CTSI lent support to development of FDA-approved, “tissue agnostic” cancer drug CTSI lent support to development of FDA-approved, “tissue agnostic” cancer drug December 03, 2018 2 min read CTSI-funded Researchers CTSI offers confidential consultations in research ethics January 24, 2017 1 min read Clinical and Translational Research Centers, Community Engagement, CTSI Leadership & Partner News CTSI partners highlighted in AAMC story on doctors forging ahead to allay fears with COVID-19 vaccines CTSI partners highlighted in AAMC story on doctors forging ahead to allay fears with COVID-19 vaccines February 01, 2021 1 min read CTSI Leadership & Partner News CTSI patient advocate named a “Health Hero” by Oprah’s magazine December 15, 2016 1 min read Pagination Previous page Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 Next page
